+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Small Molecule CMO"

Small Molecule CMO/CDMO Market Report 2025 - Product Thumbnail Image

Small Molecule CMO/CDMO Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Small Molecule Innovator CDMO Market Report 2025 - Product Thumbnail Image

Small Molecule Innovator CDMO Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Small Molecule CMO market is a subset of the Pharmaceutical Manufacturing industry, focusing on the production of small molecule drugs. Small molecule drugs are typically composed of organic molecules, and are used to treat a variety of conditions, from cancer to cardiovascular disease. CMOs provide a range of services, from drug development and clinical trials to manufacturing and packaging. They are often used to reduce the cost and time associated with drug development, as well as to increase the efficiency of the manufacturing process. CMOs are typically divided into two categories: contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). CMOs focus on the production of small molecule drugs, while CDMOs provide a range of services, from drug development to manufacturing and packaging. Companies in the Small Molecule CMO market include Boehringer Ingelheim, Catalent, Lonza, Patheon, and Recipharm. Show Less Read more